Outdoor Holding Co Income Taxes Disclosure
NOTE 13 – INCOME TAXES
The income tax (provision) benefit for the periods shown consist of the following:
|
|
2025 |
|
|
2024 |
|
|
2023 |
|
|||
Current |
|
|
|
|
|
|
|
|
|
|||
US Federal |
|
$ |
|
|
$ |
|
|
$ |
|
|||
US State |
|
|
|
|
|
|
|
|
|
|||
Total current provision |
|
|
|
|
|
|
|
|
|
|||
Deferred |
|
|
|
|
|
|
|
|
|
|||
US Federal |
|
|
(5,601,975 |
) |
|
|
(718,757 |
) |
|
|
(1,152,032 |
) |
US State |
|
|
(1,556,266 |
) |
|
|
(229,535 |
) |
|
|
(195,023 |
) |
Total deferred benefit |
|
|
(7,158,241 |
) |
|
|
(948,292 |
) |
|
|
(1,347,055 |
) |
Change in valuation allowance |
|
|
13,444,546 |
|
|
|
- |
|
|
|
— |
|
Income tax (provision) benefit |
|
$ |
6,286,305 |
|
|
$ |
(948,292 |
) |
|
$ |
(1,347,055 |
) |
The reconciliation of income tax expense computed at the U.S. federal statutory rate of 21% to the income tax provision is as follows:
|
|
2025 |
|
|
|
2024 |
|
|
|
2023 |
|
|
|||
U.S. Federal |
|
|
21.0 |
|
% |
|
|
21.0 |
|
% |
|
|
21.0 |
|
% |
State taxes, net of Federal income tax benefit |
|
|
5.5 |
|
% |
|
|
5.6 |
|
% |
|
|
6.0 |
|
% |
Change in valuation allowance |
|
|
(11.5 |
) |
% |
|
|
0.0 |
|
% |
|
|
0.0 |
|
% |
Employee stock awards |
|
|
0.1 |
|
% |
|
|
(7.4 |
) |
% |
|
|
(33.3 |
) |
% |
Equity issuance costs |
|
|
0.0 |
|
% |
|
|
0.0 |
|
% |
|
|
0.0 |
|
% |
Stock and warrants on note conversion |
|
|
0.0 |
|
% |
|
|
0.0 |
|
% |
|
|
(1.9 |
) |
% |
Stock for services |
|
|
0.0 |
|
% |
|
|
0.0 |
|
% |
|
|
0.0 |
|
% |
Non-deductible meals and entertainment |
|
|
0.0 |
|
% |
|
|
(0.1 |
) |
% |
|
|
(0.4 |
) |
% |
Contingent consideration fair value |
|
|
0.0 |
|
% |
|
|
0.1 |
|
% |
|
|
0.2 |
|
% |
Return to provision |
|
|
0.0 |
|
% |
|
|
0.0 |
|
% |
|
|
0.0 |
|
% |
Other |
|
|
0.0 |
|
% |
|
|
(0.4 |
) |
% |
|
|
(0.3 |
) |
% |
Total provision for income taxes |
|
|
15.2 |
|
% |
|
|
18.7 |
|
% |
|
|
(8.8 |
) |
% |
The Company’s effective tax rates were 15.2%, 18.7% and (8.8%) for the years ended March 31, 2025, 2024 and 2023, respectively. Prior to the year ended March 31, 2022, we accumulated net operating losses in the amount of $61.5 million. These net operating losses created a deferred tax asset which carried a valuation allowance due to uncertainty regarding the timing and ability of the Company to utilize such losses against current income. During the year ended March 31, 2023, the Company generated significant taxable income which consumed $32.3 million of net operating loss carryforwards. This caused the release of the valuation allowance in the amount of $9.4 million. During the years ended March 31, 2025 and 2024, the effective tax rate differed from the U.S. federal statutory rate primarily due to employee stock awards and changes in valuation allowance. During the year ended March 31, 2025, the Company recorded a valuation allowance of $36.0 million due to uncertainty regarding the timing and utilization of losses in future periods.
Significant components of the Company’s deferred tax liabilities and assets are as follows:
|
|
|
|
|
|
|
||
|
|
As of March 31, |
|
|||||
|
|
2025 |
|
|
2024 |
|
||
Deferred tax assets |
|
|
|
|
|
|
||
Net operating loss carryforward |
|
$ |
16,557,351 |
|
|
$ |
5,229,409 |
|
Loss on purchase |
|
|
2,213,969 |
|
|
|
2,215,611 |
|
Impairment - Ammunition segment |
|
|
12,398,990 |
|
|
|
- |
|
Inventory capitalization - Section 263A |
|
|
472,665 |
|
|
|
1,001,457 |
|
Bad debt allowance |
|
|
1,045,220 |
|
|
|
973,565 |
|
Legal reserve settlement |
|
|
7,978,747 |
|
|
|
- |
|
Non qualified stock compensation expense |
|
|
1,154,090 |
|
|
|
- |
|
Other timing differences |
|
|
481,036 |
|
|
|
297,195 |
|
Total deferred tax assets |
|
$ |
42,302,068 |
|
|
$ |
9,717,237 |
|
|
|
|
|
|
|
|
||
Deferred tax liabilities |
|
|
|
|
|
|
||
Depreciation expense |
|
$ |
(3,523,690 |
) |
|
$ |
(3,580,271 |
) |
Change in estimate and accounting method |
|
|
(699,392 |
) |
|
|
(699,910 |
) |
Amortization - intangible assets |
|
|
(2,114,232 |
) |
|
|
(1,029,565 |
) |
Total deferred tax liabilities |
|
|
(6,337,314 |
) |
|
|
(5,309,746 |
) |
Net deferred tax asset |
|
$ |
35,964,754 |
|
|
$ |
4,407,491 |
|
Valuation allowance |
|
|
(35,964,754 |
) |
|
|
- |
|
Net deferred tax asset |
|
$ |
- |
|
|
$ |
4,407,491 |
|
The Company accounts for uncertain tax positions in accordance with ASC No. 740-10-25. ASC No. 740-10-25 addresses the determination of whether tax benefits claimed or expected to be claimed on a tax return should be recorded in the financial statements. Under ASC No. 740-10-25, the Company may recognize the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefit to be recognized is measured as the largest amount of benefit that is greater than fifty percent likely of being realized upon ultimate settlement. To the extent that the final tax outcome of these matters is different than the amount recorded, such differences impact income tax expense in the period in which such determination is made. Interest and penalties, if any, related to accrued liabilities for potential tax assessments are included in income tax expense. ASC No. 740-10-25 also requires management to evaluate tax positions taken by the Company and recognize a liability if the Company has taken uncertain tax positions that more likely than not would not be sustained upon examination by applicable taxing authorities.
The Company has evaluated tax positions taken by the Company as of March 31, 2025 and 2024 in accordance with the recognition and measurement framework within ASC No. 740-10, and has concluded that the benefits associated with certain tax positions should not be recognized on the financial statements. As such, the Company has recorded an additional income tax payable on the consolidated balance sheet of $1.6 million as of March 31, 2025 and 2024. Included within this amount is accrued penalties and interest of $0.3 million. The Company records penalties and interest associated with uncertain tax positions as a component of income tax expense.
The tax periods ended March 31, 2021, 2022, 2023, 2024 and 2025 are subject to audit by the Internal Revenue Service.
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Jun 16, 2025 | Showing above |
| 2024 | Jun 13, 2024 | |
| 2023 | Jun 14, 2023 | |
| 2022 | Jun 29, 2022 | |
| 2021 | Jun 29, 2021 | |
| 2020 | Aug 19, 2020 | |
| 2019 | Jul 1, 2019 | |
| 2017 | Apr 11, 2018 | |
| 2016 | Mar 16, 2017 | |
About Income Taxes Disclosures
The income tax disclosure reveals how much a company actually pays in taxes versus what the statutory rate would predict. Analysts focus on the effective tax rate (ETR) reconciliation, which breaks down every item driving the gap between the 21% federal rate and the company's reported ETR — including R&D credits, foreign rate differentials, and state taxes. Deferred tax assets (DTAs) and their valuation allowances signal management's confidence in future profitability: a rising allowance suggests the company doubts it can use accumulated tax benefits. Uncertain tax benefit (UTB) reserves quantify exposure to IRS challenges on aggressive positions.
Key signals to watch: sudden ETR drops without clear operational reasons, large increases in valuation allowances, growing UTB balances, and significant unremitted foreign earnings. Post-TCJA, pay attention to GILTI and BEAT provisions that affect multinational tax structures. Compare the cash taxes paid (from the cash flow statement) against the income tax provision to gauge earnings quality.